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HIV-1
EnvThe majority of infection by the human immunodeﬁciency virus (HIV-1) across the world occurs by
heterosexual transmission and is likely mediated by virus present in genital secretions. In spite of this,
infection is followed by clinical markers of the virus present in blood, which may not be representative of the
virus involved in transmission. In fact, several studies have demonstrated that the genital tract represents a
unique compartment for the virus. We assessed the relationship between immune system integrity,
represented by CD4+ T cell counts, and the maintenance of viral compartmentalization between plasma and
vaginal ﬂuid virus in treatment naïve women from the Dominican Republic infected by the heterosexual
transmission route. We cloned and sequenced cell free virus from plasma and genital ﬂuid samples from six
women to assess viral evolution, phylogenetic relatedness, and calculated co-receptor use for the C2V3 region
of the envelope. Our analyses demonstrated plasma and vaginal ﬂuid virus compartments remained intact
only in samples from women with CD4+ T cell counts over 350 cells/μl. The majority of viral forms were
predicted to use the CCR5 co-receptor, although several dual tropic forms were also identiﬁed. None of the
clones were found to use the CXCR4 co-receptor even thoughmany of the patients showed severe disease. Our
ﬁndings lend further support to the role of an intact immune system in maintaining compartmentalization
across blood and genital quasispecies and provide a compelling rationale to speciﬁcally consider genital tract
viral forms in therapeutic and vaccine research.Ponce School of Medicine, PO
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A salient feature of human immunodeﬁciency virus type 1 (HIV-1)
infection is rapid and continuous accumulation of mutations in
different viral genes leading into generation of diverse viral variants
within and between HIV-infected individuals. Numerous reports have
conﬁrmed the presence of distinct HIV-1 variants, based on the
envelop analysis, in different anatomical compartments like brain,
lung, lymph nodes, spleen, gastrointestinal and genital tracts, kidney
and peripheral blood mononuclear cells (PBMC)(Barnett et al., 1991;
Delassus et al., 1992; Dittmar et al., 1997; Donaldson et al., 1994;
Epstein et al., 1991; Gratton et al., 2000; Gupta et al., 2000; Haggerty
and Stevenson, 1991; Hughes et al., 1997; Itescu et al., 1994; Kemal etal., 2003; Keys et al., 1993; Korber et al., 1994; Marras et al., 2002;
Ohagen et al., 2003; Overbaugh et al., 1996; Poss et al., 1995, 1998;
Reddy et al., 1996). Likewise pol has been used to deﬁne differential
evolution of the virus in diverse tissue compartments (Haddad et al.,
2000; Potter et al., 2003; Tirado et al., 2004a,b; Wang et al., 2000;
Wong et al., 1997).
The exact reasons for virus compartmentalization have not been
fully deﬁned. Clearly several factors are involved including immune
selective pressures, differential penetration of antiretroviral medica-
tions, and distinct target cell populations present in different niche
environments throughout the host. These variants in different
anatomical compartments pose new challenges for the management
of viral infection and vaccine development strategies.
Heterosexual transmission is a major component of the spread of
HIV-1 infection with genital mucosa serving as site of the initial
contact. Therefore study of the virus genotype in male and female
genital compartments is critical to understand the viral pathogenesis,
the development of vaccines, treatment strategies and blockage of
heterosexual transmission. Furthermore study of the virus genotype
in the female genital compartment may offer strategies to block not
321S. Chaudhary et al. / Virology 417 (2011) 320–326only the heterosexual transmission but also mother-to-child transmis-
sion. The relatively few existing studies, including some by our group,
that have attempted to identify and characterize the virus in systemic
and genital compartments of HIV-infected female (Andreoletti et al.,
2007; Kemal et al., 2003; Overbaugh et al., 1996; Philpott et al., 2005;
Poss et al., 1995, 1998; Sullivan et al., 2005; Tirado et al., 2004a,b) have
shown distinct variants between vaginal and blood compartments.
However these studies did not focus on the effect of CD4+ T cell counts
on virus evolution in systemic and genital compartments. In view of our
recent ﬁndings that higher CD4+ T cell counts causes monophylectic
clustering of envelop sequences in patients undergoing highly active
antiretroviral therapy (HAART)(Lorenzo et al., 2004), we decided to
determine theeffect of CD4+T cell counts on virus evolution in systemic
and genital compartments. In this study we examined 6 HIV-infected
females who acquired the virus by heterosexual transmission and
examined thevirus collected fromplasmaandvaginalﬂuid for sequence
variation (silent as well as non-silentmutation), co-receptor usage, and
changes in glycosylation sites.
Results
Six females enrolled for the study comprised two separate
groups summarized in Table 1. Two individuals with relatively higher
CD4+ counts (001M—450 and 007M—368 CD4+T cells/μl blood) and
4 individuals with very low CD4+ counts (027M—16; 006M—38;
003M—50; and 005M—178 CD4+T cells/μl blood). The viral load in
the plasma ranged between 3536 and 750,000 RNA copies/ml
whereas in the vaginal ﬂuid it ranged from below the level of
detection to a maximum of 10,745 RNA copies/ml. Heterosexual
exposure was reported to be only risk factor responsible for HIV
transmission in all 6 females. These females were classiﬁed for disease
status using the CDC 1993 classiﬁcation (1992).
Intracompartmental diversity is independent of viral load and CD4+
T cell level
Phylogenetic analyses of C2V3 envelope variants within the
plasma compartment and the vaginal ﬂuid compartment were
performed by calculation of average sequence divergence within
compartment using a maximum composite likelihoodmodel (Tamura
et al., 2004) in samples from six heterosexually infected women from
the Dominican Republic (Table 2). Examination of both plasma and
vaginal ﬂuid compartmental diversity showed variation ranging from
less than 1% to greater than 7% for the C2V3 region, which
encompasses the co-receptor binding determinants. No correlation
was found by comparing intracompartmental diversity in cell free
viral sequences against viral loads in either plasma or in vaginal ﬂuid
samples or CD4+ T cell counts (Table 1). Participant 001M had theTable 1
Virological, immunological and clinical characteristics of therapy naïve women from Domin
ID Clinicala Age Viral loadb CD4+
cells/uRNA copy Eq/ml
Plasma VF/ultra
001M D 29 120,148 b400/555 450
007M 30 3536 b400 368
005M P 25 31,541 b400/b50 178
003M 23 750,000 842 50
006M P 23 611,092 b400/10,745 38
027M 30 128,037 b400/292 16
Het—Known heterosexual partner with HIV-1 risk, IDU-injection drug use.
a Clinical symptoms at the time of ﬁrst visit to clinic, D-diabetic, P-pneumonia.
b The viral loads were determined by HIV-1 monitor system for plasma and ultra sensiti
c The CD4 cell count was determined by staining PBMC monoclonal antibodies against CD
(obtained from complete blood count) and percentage of CD4-positive cells in ﬂow cytomehighest T cell count (450 cells/μl) and the second highest total plasma
diversity of 2.2%, but with a low vaginal ﬂuid diversity of 0.4%. These
values are similar to four (003M, 005M, 007M and 027M) of the
remaining ﬁve participants in plasma and vaginal ﬂuid sample diversity
(ranging from 0.2% to 1.7% across all plasma and vaginal ﬂuid
compartmental diversity values, except 027M where only a single viral
formwas identiﬁed in vaginal ﬂuid), even while the CD4+ T-cell counts
among those four samples ranged as low as 16 cells/μl. In contrast, a
single participant exhibited high intracompartmental diversity in both
plasma and vaginal ﬂuid (06M at 5.3% and 7.3%, respectively) while
having the second lowest CD4+ counts of the group (Table 2). Thus no
direct trends between intracompartmental divergence (compartmental
diversity) and either viral load or CD4+ counts were observed. Table 1
indicates that viral loads in plasma and vaginal ﬂuid likewise did not
correlate with maintenance of CD4+ T cell integrity.Integrity of compartmentalization correlates directly with CD4+ T cell
counts
In contrast to our analysis of intracompartmental diversity vs.
CD4+ T cells, the between compartment divergence showed a direct
relationship to CD4+ levels. Table 2 shows that the net evolutionary
divergence between compartments, calculated using the maximum
composite likelihood model with 500 bootstrap replicates to
determine standard error, trends toward higher values with higher
CD4+ T cell counts. Samples from participant 001M, with the highest
CD4+ T cell counts of 450 cells/μl also had the largest net divergence
between plasma and vaginal ﬂuid virus of 12.5%+/− 3.1%. Participant
007M had the second highest net divergence (0.9%+/− 0.8%) and the
second highest CD4+ T cell count (368 cells/μl). All other participants
had net divergence between compartment values of well under 1%.
Due to presence of a single clone identiﬁed in vaginal ﬂuid, net
divergence was not calculated for participant 027M.
In addition to Table 2, phylogenetic trees were constructed to
illustrate the extent of compartmental separation between virus
derived from plasma and vaginal ﬂuid. Maximum likelihood evolu-
tionary history for sequences within each patient was calculated and
trees were generated (Fig. 1) and statistically assessed by boot-
strapping (500 replicates). Trees for participant 001M and 007M,
450 cells/μl and 368 cells/μl, clearly show separation of plasma (closed
circles) and vaginal ﬂuid (open circles) clones. The other four
participants, with CD4+ T cell counts under 200 fail to demonstrate
compartmentalization, but rather show mixing of plasma and vaginal
ﬂuid forms within the same branches. These data more clearly
indicate the integrity of compartmentalization of viral forms for CD4+
counts over 350 cells/μl and the loss at lower levels of CD4+ T cells.
Further examination of synonymous and non-synonymous substitu-
tion rates (Table 4) across virus in plasma and vaginal ﬂuid using theican Republic.
lc
Pattern of
HIV-1
Drug use
(6 months)
Reported
lifetime
partners
HIV risk
factor
Compartmental None 2 Het
Compartmental None Het
Intermingled None Het
Intermingled None Sex worker Het/IDU
Intermingled None 2 Het
Intermingled None Het
ve for vaginal ﬂuid.
3 and CD4. The absolute CD4 count was calculated by multiplying lymphocyte numbers
try.
Table 2
Divergence across compartments and diversity within compartments for untreated female patients.
001M 007M 005M 003M 006M 027M
Net P-VF divergencea 12.5%±3.1 0.9%±0.8 0.01%±0.04 0.02%±0.2 0.5%±0.5 NCb
Plasma diversityc 2.2%±0.7 0.2%±0.3 0.5%±0.4 1.5%±0.7 5.3%±1.2 0.8%±0.3
Vaginal Fluid Diversityc 0.4%±0.2 1.4%±0.9 1.2%±0.7 1.7%±0.7 7.3%±1.8 0%±0
a Divergence calculated from base substitutions per site of net average between groups.
b NC—not calculated.
c Diversity indicates base substitution per site of average over all sequence pairs for each sample.
322 S. Chaudhary et al. / Virology 417 (2011) 320–326SNAP program provide an indication of statistically signiﬁcant
selective forces only in the participant with the highest CD4+ counts
(001M), in agreement with the net-divergence (Table 2) and
phylogenetic predictions in Fig. 1. Each of the other samples for
which dS/dN ratios could be calculated, failed to show signiﬁcant
mean ratios (Table 4), and notably had very low CD4+ counts. Sample
007M, with the second highest CD4+ counts failed to demonstrate
sufﬁcient levels of synonymous changes in plasma to perform this
calculation.
Co-receptor switch with progression is more prevalent in the vaginal
ﬂuid viral compartment
We did not obtain information related to the length of time since
initial infection for any of the women in this study, although four of six
have CD4+ counts below 200 cells/μl, an immunological criterion for
AIDS diagnosis. Furthermore, two of the participants presented
pneumonia at time of ﬁrst clinic visit, again supporting the advanced
stage of HIV infection (Table 1). Interestingly, analysis of the co-
receptor binding motif in the C2V3 amino acid sequence provided
almost no evidence of an R5 to X4 co-receptor switch that is
frequently associated with progression to AIDS Table 3 and Fig. 2.
Co-receptor predictionwas nearly uniform in deﬁning sequenceswith
the R5 genotype among the entire cohort. Several clones with
potentially dual tropic viral forms were deﬁned. Though relatively001M
007M
100
97
100
71
81
0.02
90
0.02
Fig. 1.Maximum likelihoodmodel phylogenetic analysis shows compartmentalization in pat
evolutionary history. Trees indicate phylogenetic relationship of clones isolated from vagin
001M and 007M trees indicate separation of clones from plasma and vaginal ﬂuid (leftmos
027M, 006M (rightmost tree) fail to show separate clusters of plasma and vaginal ﬂuid clone
than 70 are shown to indicate strength of clustering patterns.few in plasma, 66% of the 03M plasma clones, several samples
indicated the presence of dual tropic viral envelopes in vaginal ﬂuid,
~20% of 003M, 66% of 006M, and all 027M vaginal ﬂuid clones were
predicted as dual tropic.
Discussion
Our results suggest a positive relationship between maintenance
of viral compartments at the C2V3 region of the envelope gene within
the host and the integrity of the CD4+ T cell population. Our group
previously found a loss of viral compartmentalization between
vaginal ﬂuid and plasma for the pol gene in a report of an individual
with a CD4+ T cell count under 50 cells/μl that showed drug resistance
mutations in the absence of ART (Tirado et al., 2004a). Several other
studies have identiﬁed interesting patterns of viral load concordance
between vaginal ﬂuid and plasma. For example, analysis of over
seventy women found detectable virus in 85% of plasma samples,
while virus was detected in only 39% of the same individuals at
coincident vaginal ﬂuid sampling (Uvin and Caliendo, 1997).
However, when the data were stratiﬁed by CD4+ counts, 67% of
patients exhibited concordant detection of virus in plasma and vaginal
ﬂuid from a single time point. This study was unable to differentiate
the role of loss of immune control of viral replication within
compartments versus mixing of virus across compartments in driving
the concordant detection of virus in plasma and vaginal ﬂuid with005M
003M
80
027M
006M94
94
86
99
0.02
ients with higher CD4+ T cell counts. Maximum likelihoodmodel was employed to infer
al ﬂuid (closed circles) or plasma (open circles) from simultaneous samples. Patients
t tree). The phylogenetic arrangements of clones from 005M, 003M (middle tree) and
s. Scale bars indicate 2 nucleotide changes per 1000 positions. Bootstrap values greater
Table 3
Predicted co-receptor use of clones isolated from plasma and vaginal ﬂuid of treatment
naïve females.
Patient R5 Dual X4
001M Plasma 8 – –
VF 9 – –
007M Plasma 9 – –
VF 4 – –
005M Plasma 6 – –
VF 6 – –
003M Plasma 2 4 –
VF 5 1 –
006M Plasma 7 – –
VF 1 2 –
027M Plasma 12 – –
VF – 3 –
Co-receptor use predicted using Web PSSM.
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data showing loss of compartmentalization with lower CD4+ T cells.
In addition, only 50% of compartmentalized patients versus 75% of
intermingled participants, showed detectable viral loads across
plasma and vaginal ﬂuid samples (Table 1).
Several other groups have reported a direct relationship between
higher CD4+ counts and viral compartmentalization in the female
genital tract compared with plasma. Kemal, et al. found correlation
between higher CD4+ levels and distinct viral populations in plasma
and vaginal tract cell-free virus (Kemal et al., 2003). Their study used
cervico-vaginal lavage, which obtains virus from endocervix, vagina
and fornix and represents a larger portion of the lower genital tract
than our vaginal swab sampling assessed, indicating a greater extent
of tissue is compartmentalized. A later study by the same group
analyzed full length RNA genomes from plasma and female genital
tract and found strong evidence for compartmentalization (Philpott et
al., 2005). Interestingly, the association between CD4+ T cell levels
and compartmentalization was less clear, as only a single study
subject showed intermingled viral forms in the two compartments
and this study subject had counts of 306 cells/μl. In contrast, three
participants had lower counts and showed compartmentalization.
There was evidence for recombination between plasma and vaginal
tract virus in the patient with the lowest CD4 counts (6 cells/μl). This
suggested mixing of virus between plasma and the female genital
tract had occurred and perhaps the viral forms represented inﬂuence
of recent replication as this individual had a genital tract viral load of
2.5 million copies/ml (Philpott et al., 2005). A different study of cladeTable 4
Mean synonymous and non-synonymous nucleotide substitution changes in different cell-f
Sample Mean ds±SD P valuea M
001 M Plasma 0.0292±0.0104 0.08 0.
Vaginal 0.0425±0.0071 0.
007 M Plasma 0.0000±0.0000 0.83 0.
Vaginal 0.0400±.0.0000 0.
005 M Plasma 0.0257±0.0098 0.16 0.
Vaginal 0.0200±0.0000 0.
003 M Plasma 0.0660±0.0260 0.63 0.
Vaginal 0.0700±0.0263 0.
006 M Plasma 0.0935±0.0448 0.11 0.
Vaginal 0.1267±0.0513 0.
027 M Plasma 0.0221±0.0063 0.10 0.
Vaginal 0.0000±0.0000 0.
ϕ There are not enough valid cases to perform the Wilcoxon Signed Rank Test for dsdnplasm
Patient 1 showed a difference in the non-synonymous nucleotide substitutions (p=0.02) a
No statistical signiﬁcance differences were found in the patients 3, 5, 6, 7 and 27.
a P values calculated by Wilcoxon's signed rank test.A infection demonstrated clear blood and genital ﬂuid viral compart-
mentalization in four women with clinically asymptomatic HIV-1
infection, again arguing for a strong role of the intact immune
response in maintaining divergence of virus across compartments
(Andreoletti et al., 2007). Sullivan et al., have also reported an
association between CD4+ levels and viral divergence using hetero-
duplex mobility shift analysis of env C2V4, which they suggested was
evidence for immune status in maintenance of compartmentalization
(Sullivan et al., 2005). Thus our data further support the suggestion
that the immune response impacts the compartmentalization of viral
forms in genital and plasma ﬂuids.
The important role of an intact immune system in maintaining
selective pressure on HIV is a clear function of the CD4+ T cell sub-set;
however, the role of the CD4+ T cells in this phenomenon in our
dataset is more complex. Only a single participant, 001M, had
evidence for immune selection according to calculation of the
synonymous:non-synonymous change ratio. Yet the viral load for
this patient demonstrated loss of control of the virus at time of
sampling, suggesting the selection either occurred prior to sampling
or was driven by other factors like target cell repertoire within the
compartment. Alternatively, this may represent emergence of an
archival form.
Initial comparison of plasma-vaginal ﬂuid compartment diver-
gence showed a rough correlation with CD4+ T cell level; however,
patient 006M clearly showed high intracompartmental diversity even
with a very low cell count, again indicating a complex role. Upon
closer examination, this patient was remarkable in having high
diversity in both plasma and vaginal ﬂuid, particularly in comparison
with the overall plasma-vaginal ﬂuid divergence, whichwas quite low
at 0.5%. In Fig. 1 and Table 2, we clearly observe a direct relationship
between compartmental separation and CD4+ T cells over
350 cells/μl. Thus divergence between compartments is only main-
tained at higher CD4+ levels. This may suggest that T cells are
important for establishing or at least maintaining distinctions in the
niches of viral replication in different anatomical regions of the host,
whether or not the diversity within those niches is controlled. Thus
the breakdown in the CD4+ T cell compartment by loss below 200
may result in loss of host compartmental selective forces thus
allowing the systemic viral forms to become more uniform. In the
case of 006M, since the intracompartment diversity is already high,
the intercompartmental divergence represents greater diversity of
forms within the entire host, rather than maintenance of unique viral
niches, thus the net divergence is quite low. In contrast, no other
patient has high diversity in both plasma and vaginal ﬂuid. Among
these ﬁve study participants, the intercompartmental divergence
more closely follows a direct comparison with CD4+ levels.ree compartments of therapy naïve females.
ean dn±SD P valuea Mean ds/dn±SD P valuea
0238±0.0120 0.02 1.3369±0.4575 0.01
0100±0.0000 7.3713±1.2763
0067±0.0048 0.11 0.0000±0.0000 ϕ
0300±0.0100 1.4444±0.5092
0114±0.0038 1.00 3.6014±2.4277 0.50
0100±0.0000 2.9800±0.8600
0210±0.0129 0.89 5.3200±4.7624 0.65
0183±0.0112 6.2383±3.6943
0460±0.0274 0.18 3.5145±3.2352 0.59
0567±0.0322 2.3100±0.5200
0111±0.0032 0.08 2.1053±0.7375 ϕ
0000±0.0000 undeﬁned
a vs dsdnvaginal.
nd ds/dn (P=0.01) between plasma and vaginal samples.
Fig. 2. Inferred amino acid alignment of C2V3 HIV-1 env sequences from plasma and vaginal ﬂuid derived clones in therapy naïve females. Amino acid changes are indicated relative
to the C2V3 sequence as a reference sequence generated by the BioEdit. Identical clones within each patient are not shown, but clones appearing multiple times are indicated in
parentheses after clone names. Dots indicate identical amino acid sequences, dashes indicate deletions.
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Study cohort and sample preparation
Six 23–30 year-old females from Dominican Republic were
enrolled in the study. An informed consent was obtained from these
individuals. The clinical proﬁle of these individuals is shown in
Table 1. Paired blood and vaginal swab samples were collected. 20 ml
blood was collected from each female of which 2 aliquots of 200 μl
were used for complete blood count (CBC) and CD4+ T-cell count,
respectively. The remaining blood was centrifuged at 3000 rpm for
10 min to separate the plasma. Plasma was frozen at −85 °C and an
aliquot of that was used for viral RNA extraction. Vaginal secretion
was collected by using 2 Dacron-tipped applicators and taking swabs
from the cervico-vaginal area. The swabs were vigorously washed in
2 ml of R-10 (RPMI-1640, HEPES and 10% human AB plasma) to
release the virus and loosen cells before being removed from tubes.
The amount of vaginal secretions retained by each tip was calculated
to be 133 μl by a dye dilution method. The vaginal cells were
separated by centrifugation at 1000 rpm for 10 min and supernatants
were ﬁltered through a 0.2 μm pore membrane ﬁlter. All vaginal ﬂuid
aliquots were frozen at−85 °C until used for virus load determination
and sequencing.Viral load in plasma and vaginal ﬂuid and CD4+ counts in the blood
Plasma and vaginal HIV-1 RNA viral loads were assessed using the
Amplicor HIV-1 Monitor test standard specimen processing (Roche
Diagnostics Corp., NJ). In case the viral load in a particular sample was
found below the level of detection (b400 copies/ml), an ultra-
sensitive specimen processing procedure was used to determine the
viral loads. During sample preparation, since the vaginal ﬂuids were
diluted 8.5-fold (i.e., 2×133 μl vaginal ﬂuid diluted in the ﬁnal volume
of 2266 μl medium), the viral load in vaginal ﬂuid was, therefore,
expressed as (Assay Value)×8.5. The CD4+ T-cell percentage was
determined by ﬂow cytometry and the absolute CD4+ T cell number
was calculated using percentage CD4+ T cell count and lymphocyte
numbers per μl blood, obtained from CBC.
RNA extraction and RT-PCR
HIV-1 RNA was extracted from plasma and vaginal ﬂuid using the
QIAmp Viral RNA Mini Kit (QIAGEN, Valencia, CA) as described
previously (Tirado et al., 2004b). In patient 005M with undetectable
viral load (b50 copies/ml), approximately 2 ml of vaginal ﬂuid sample
was applied to the same column followed by other steps as
recommended by manufacturer for extraction of very low viral load
325S. Chaudhary et al. / Virology 417 (2011) 320–326samples. A 541 base pair fragment (nucleotides 7001-7541, HXB2)
was ampliﬁed using a nested PCR protocol. The ﬁrst ampliﬁcation
utilized a RT-PCR reaction with 100 ng RNA, ready-to-go RT-PCR beads
(AmershamBioscience, Piscataway, NJ), forward (F 5′-CCTCAGTCATTA-
CACAGGCCTGTCCAAAG-3′) and reverse primers (5′-AGTGCTTCCT-
GCTGCTCCCAAGAACCCAA-3′) in a 50 μl reaction mixture. The PCR
conditions included 1 cycle of reverse transcription (42 °C for 30 min),
followed by denaturation at 95 °C for 5 min, 35 cycles of ampliﬁcation
(95 °C-30 s, 60 °C-30 s and 72 °C-1 min) and ﬁnal elongation at 72° for
5 min. 1 μl of 1st round PCR product was ampliﬁed in a nested PCR
reaction using a forward (5′-CTGTTAAATGGCAGTCTAGC-3′) and re-
verse primer (5′-TGATGGGAGGGGCATACATT-3′) following the PCR
conditions above (except reverse transcription step). The PCR product
was resolved on 1.5% agarose, stained with ethidium bromide and
visualized under ultraviolet light for size conﬁrmation.
Cloning and sequencing of the PCR product
The PCR products were cloned into a TA vector according to TOPO
TA Cloning Kit protocol (Invitrogen, Carlsbad, CA). The plasmid DNA
was puriﬁed (QIAprep Spin column, QIAGEN) and sequenced using a
7-Deaza-dGTP Cy5/CY5.5 DYE primer kit and automated DNA
sequencer (Visible Genetics, Toronto, ON, Canada).
C2-V3 sequence analysis
A213base pair sequence covering the C2-V3 segmentwas ampliﬁed
from plasma and vaginal ﬂuid (VF) viruses for analysis. The nucleotide
sequenceswere alignedwith BioEdit version 5.0.9 (Hall, 1999) followed
by manual editing. The evolutionary analyses were made by maximum
composite likelihood model (Tamura et al., 2004) and trees were
inferred using 500 bootstrap replicates for statistical analysis. The trees
were visualized using MEGA 5(Tamura et al., 2011). Potential N-linked
glycosylation sites were determined by using the N-glycosite tool from
Los Alamos sequence database.
The V3 sequences were also used for the prediction of coreceptor
usage as described previously (Jensen et al., 2003). This program
reliably predicts CXCR4 usage (sensitivity, 84% and speciﬁcity, 96%) by
scoring V3 amino acids. This score is based on the basis of position-
speciﬁc scoring matrices (PSSM) that predicts the co-receptor type. A
low score suggests presence of CCR5 binding motif whereas an
intermediate score predicts R5X4 virus and a high score suggests X4
virus.
Nucleotide sequence accession numbers
The sequence discussed in this work can be found in Genbank
under accession numbers AY621091 to AY621092, AY624587 to
AY624601, AY626150 to AY626155, AY623936 to AY623964,
DQ060305 to DQ060317 and DQ205915 to DQ205929.
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